William Blair lowered shares of Express Scripts (NASDAQ:ESRX) from an outperform rating to a market perform rating in a report released on Thursday. William Blair also issued estimates for Express Scripts’ Q4 2018 earnings at $2.72 EPS.
Several other analysts have also commented on the company. Jefferies Group lowered Express Scripts from a buy rating to a hold rating and set a $91.00 price target on the stock. in a research note on Thursday. Maxim Group lowered Express Scripts from a buy rating to a hold rating in a research note on Thursday. Barclays assumed coverage on Express Scripts in a research note on Thursday. They issued an equal weight rating and a $84.00 price target on the stock. Zacks Investment Research raised Express Scripts from a hold rating to a buy rating and set a $84.00 price target on the stock in a research note on Tuesday, March 6th. Finally, Bank of America assumed coverage on Express Scripts in a research note on Tuesday, February 27th. They issued an underperform rating and a $77.00 price target on the stock. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have given a buy rating to the company’s stock. Express Scripts currently has a consensus rating of Hold and an average target price of $81.97.
Shares of Express Scripts (ESRX) opened at $80.75 on Thursday. Express Scripts has a fifty-two week low of $55.80 and a fifty-two week high of $85.07. The firm has a market capitalization of $45,320.00, a P/E ratio of 10.43, a PEG ratio of 0.99 and a beta of 0.94. The company has a current ratio of 0.67, a quick ratio of 0.55 and a debt-to-equity ratio of 0.83.
Express Scripts announced that its board has authorized a share repurchase program on Monday, December 18th that permits the company to buyback 45,000,000 shares. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.
In other news, VP Everett Neville sold 4,895 shares of the business’s stock in a transaction on Thursday, March 1st. The stock was sold at an average price of $75.26, for a total transaction of $368,397.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Christine Houston sold 10,104 shares of the business’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $70.08, for a total value of $708,088.32. Following the sale, the vice president now owns 87,400 shares of the company’s stock, valued at approximately $6,124,992. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 21,896 shares of company stock valued at $1,617,903. 0.68% of the stock is currently owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in the company. Fairfield Bush & CO. bought a new stake in Express Scripts in the fourth quarter valued at about $226,000. Xact Kapitalforvaltning AB increased its holdings in Express Scripts by 5.2% in the fourth quarter. Xact Kapitalforvaltning AB now owns 102,730 shares of the company’s stock valued at $7,668,000 after purchasing an additional 5,123 shares during the last quarter. Envestnet Asset Management Inc. increased its holdings in Express Scripts by 52.3% in the fourth quarter. Envestnet Asset Management Inc. now owns 179,586 shares of the company’s stock valued at $13,404,000 after purchasing an additional 61,657 shares during the last quarter. CNB Bank bought a new stake in Express Scripts in the fourth quarter valued at about $326,000. Finally, Hikari Tsushin Inc. bought a new stake in Express Scripts in the fourth quarter valued at about $1,344,000. Institutional investors own 87.70% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Express Scripts (ESRX) Downgraded to “Market Perform” at William Blair” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/3256371/express-scripts-esrx-downgraded-to-market-perform-at-william-blair.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.